Research and Developments

Page 14 of 20« First...1213141516...20...Last »

June 1, 2011

AMD Report From ARVO 2011

Posted in: Research and Developments

by Dan Roberts It is important to note at the outset of this report that patients are highly respected across the professional board for their willingness to act as pioneers in the ongoing research. Our participation in clinical trials is greatly appreciated by the researchers. That having been said, here are latest updates on research
read more »

June 1, 2011

Summary of Research and Developments in Macular Degeneration, 2010-2011

Posted in: Research and Developments

by Dan Roberts June 19, 2011 Introduction Since 2006, I have done my best to condense the high points of the previous year’s macular degeneration research into a single report that is concise and understandable for the layperson. I do so, because I understand first hand how important it is to be aware of everything
read more »

May 30, 2011

Encapsulated Cell Technology (ECT)–A New Drug Delivery System

Posted in: Research and Developments

by Dan Roberts Updated March 30, 2015 A means of delivering drugs into the retina on a time release basis is being developed and proven safe and effective. It is achieved by a method called Encapsulated Cell Technology (ECT), being tested by Neurotech SA with support from the National Eye Institute (NEI), Bethesda, Maryland. A
read more »

April 22, 2011

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

Posted in: Research and Developments

The CATT Research Group April 2011 In 2005, clinical trials established the efficacy of ranibizumab (Lucentis, Genentech) for the treatment of neovascular age-related macular degeneration (AMD), the leading cause of legal blindness in the United States. While awaiting approval for ranibizumab from the Food and Drug Administration, ophthalmologists began treating neovascular AMD with off-label use
read more »

September 14, 2010

A Primer on the Use of Stem Cells in Ophthalmology

Posted in: Research and Developments

Irving J. Arons September 2, 2010 (Version 3, Updated September 14, 2010) I recently came across an interesting news release from International Stem Cell Corporation (ISCO) announcing that it had formed a new business unit, Cytovis, to focus on stem cell programs in ophthalmology, including CytoCor for the cornea and CytoRet for the retina. That
read more »

July 22, 2010

Spikes in IOP May Result From Particulate Matter in Avastin

Posted in: Research and Developments

by Dan Roberts In a presentation to Hawaiian Eye 2010, Malik Y. Kahook, MD, said that Avastin (bevacizumab) stored for long periods of time shows evidence of increased large particulate matter. This debris can block the eye’s trabecular network and lead to increased intraocular pressure (IOP) in patients being treated with the drug for wet
read more »

June 1, 2010

Summary of Research and Developments in Macular Degeneration: 2009-2010

Posted in: Research and Developments

by Dan Roberts June 10, 2010 Introduction If I were to describe the past twelve months in a word, it would be “progress.” No spectacular breakthroughs have occurred during that time to make big news in the AMD world, but a lot of persistent work has been reaping promising results. moving us ever closer to
read more »

May 16, 2010

Genetic testing sheds light on degenerative eye disease

Posted in: Latest News, Research and Developments

Press Release February 13, 2007 Updated 5/16/2010 ANN ARBOR, Mich. — Genetic testing for eye disease is providing vital information about complex retinal diseases, especially when used to confirm a clinician’s diagnosis. In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center,
read more »

February 3, 2010

Study Shows Lucentis and Avastin to be Equal

Posted in: Latest News, Research and Developments

by Dan Roberts February 3, 2010 Investigators at Kaiser Permanente Southern California in Pasadena reported in the February 2010 issue of Ophthalmology that Avastin and Lucentis performed equally in recent testing. In an indirect comparison of the two drugs, study author Dr. Donald Fong and coauthors reviewed the records of 452 patients treated for wet
read more »

January 30, 2010

PEG-POD – New Gene Delivery Tool

Posted in: Latest News, Research and Developments

by Dan Roberts January 2010 Researchers have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone. The study was published in the January 2010 issue of The Journal of Gene Medicine by Tufts University School of Medicine and the Sackler
read more »

Page 14 of 20« First...1213141516...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann